Your browser doesn't support javascript.
loading
Cognitive impairment, fatigue and depression in multiple sclerosis: Is there a difference between benign and non-benign MS?
Bogaardt, Hans; Golan, Daniel; Barrera, Marissa A; Attrill, Stacie; Kaczmarek, Olivia; Zarif, Myassar; Bumstead, Barbara; Buhse, Marijean; Wilken, Jeffrey; Doniger, Glen M; Hancock, Laura M; Penner, Iris-Katharina; Halper, June; Morrow, Sarah A; Covey, Thomas J; Gudesblatt, Mark.
Afiliación
  • Bogaardt H; School of Allied Health Science and Practice, University of Adelaide, Adelaide, Australia. Electronic address: hans.bogaardt@adelaide.edu.au.
  • Golan D; Multiple Sclerosis and Neuroimmunology Center, Clalit Health Services, Nazareth, Israel; Department of Neurology, Lady Davis Carmel Medical Center, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Barrera MA; Katz School of Science and Health, Yeshiva University, New York, United States.
  • Attrill S; School of Allied Health Science and Practice, University of Adelaide, Adelaide, Australia.
  • Kaczmarek O; South Shore Neurologic Associates, New York, United States.
  • Zarif M; South Shore Neurologic Associates, New York, United States.
  • Bumstead B; South Shore Neurologic Associates, New York, United States.
  • Buhse M; South Shore Neurologic Associates, New York, United States; Department of Nursing, State University of Stony Brook, Stony Brook, NY, United States.
  • Wilken J; Georgetown University Dept of Neurology, Washington D.C. United States; Washington Neuropsychology Research Group, LLC., Fairfax, VA, United States.
  • Doniger GM; Department of Clinical Research, NeuroTrax Corporation, Modiin, Israel.
  • Hancock LM; Department of Neurology, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States.
  • Penner IK; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Switzerland.
  • Halper J; Consortium of Multiple Sclerosis Centers, Hackensack, NJ, United States.
  • Morrow SA; London Health Sciences Centre, University Hospital, University of Western Ontario (Western), Canada.
  • Covey TJ; Division of Cognitive and Behavioral Neurosciences, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, United States; Neuroscience Program, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, United State
  • Gudesblatt M; Katz School of Science and Health, Yeshiva University, New York, United States.
Mult Scler Relat Disord ; 73: 104630, 2023 May.
Article en En | MEDLINE | ID: mdl-36965219
INTRODUCTION: Multiple Sclerosis (MS) is a chronic inflammatory and degenerative disease of the central nervous system (CNS). The severity of disability in people with MS (PwMS) is generally measured with the Expanded Disability Status Scale (EDSS). A variant of MS known as 'benign MS' (BMS) has been defined as an EDSS score of 3 or lower, combined with a disease duration of 10 years or longer; however, there is disagreement in the field about whether BMS really exists. Given that the EDSS does not capture cognitive issues, communication dysfunction, fatigue, depression, or anxiety properly, its ability to accurately represent disability in all PwMS, including BMS, remains questionable. METHODS: In this study, 141 persons with BMS (PwBMS) were included, consisting of 115 females (82%) and 26 males (18%) with a mean age of 50.8 (±8.68). A computerized test battery (NeuroTrax®) was used to assess cognition, covering seven cognitive domains (memory, executive function, visual-spatial processing, verbal function, attention, information processing, and motor skills). Fatigue was measured using the Fatigue Severity Scale (FSS). The Beck Depression Inventory (BDI) was used to assess symptoms of depression. Cognitive impairment was defined for this study as when someone has a score lower than 85 in at least two subdomains of the cognitive test battery. Rates of impairment were compared to 158 persons with non-benign MS (PwNBMS; with a disease duration of 10 years and longer and an EDSS score higher than 3) and 487 PwMS with a disease duration of fewer than 10 years. RESULTS: Cognitive impairment was found in 38% of PwBMS and in 66% of PwNBMS (p<0.001). In PwBMS, the lowest rate of impairment was found in the verbal function domain (18%) and the highest rate of impairment in the domain of information processing (32%). Fatigue and depression were found in 78% and 55% of all PwBMS, with no difference in these rates between PwBMS and PwNBMS (p = 0.787 and p = 0.316 resp.) CONCLUSION: Cognitive impairment, fatigue and depression are common among people with an EDSS-based definition of benign MS. These aspects should be incorporated into a new and better definition of truly benign MS.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Disfunción Cognitiva / Esclerosis Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Relat Disord Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Disfunción Cognitiva / Esclerosis Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Relat Disord Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos